Cost Effectiveness of Oral Terbinafine (Lamisil®) Compared with Oral Fluconazole (Diflucan®) in the Treatment of Patients with Toenail Onychomycosis

被引：0
|
作者：
Heini Salo
Markku Pekurinen
机构：
[1] Health Services Research Ltd,
[2] STAKES,undefined
来源：
PharmacoEconomics | 2002年 / 20卷
关键词：
Cost Effectiveness; Fluconazole; Terbinafine; Clinical Cure; Mycological Cure;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Objective: To determine the cost effectiveness of terbinafine (Lamisil®)1 tablets compared with fluconazole (Diflucan® ) capsules in the treatment of patients with toenail onychomycosis.
引用
收藏
页码：319 / 324
页数：5
相关论文
共 50 条
  • [1] Cost effectiveness of oral terbinafine (Lamisil®) compared with oral fluconazole (Diflucan®) in the treatment of patients with toenail onychomycosis
    Salo, H
    Pekurinen, M
    PHARMACOECONOMICS, 2002, 20 (05) : 319 - 324
  • [2] A double-blind, randomized study to compare the efficacy and safety of terbinafine (Lamisil®) with fluconazole (Diflucan®) in the treatment of onychomycosis
    Havu, V
    Heikkilä, H
    Kuokkanen, K
    Nuutinen, M
    Rantanen, T
    Saari, S
    Stubb, S
    Suhonen, R
    Turjanmaa, K
    BRITISH JOURNAL OF DERMATOLOGY, 2000, 142 (01) : 97 - 102
  • [3] Safety of oral terbinafine for toenail onychomycosis
    Pollak, R
    Billstein, SA
    JOURNAL OF THE AMERICAN PODIATRIC MEDICAL ASSOCIATION, 1997, 87 (12): : 565 - 570
  • [4] Oral terbinafine treatment for toenail onychomycosis: reply from authors
    Molin, L
    Tarstedt, M
    Engman, C
    BRITISH JOURNAL OF DERMATOLOGY, 2001, 144 (05) : 1098 - 1099
  • [5] Combination of oral terbinafine and topical ciclopirox compared to oral terbinafine for the treatment of onychomycosis
    Avner, S
    Nir, N
    Henri, T
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2005, 16 (5-6) : 327 - 330
  • [6] Oral terbinafine in the treatment of toenail onychomycosis: North American multicenter trial
    Drake, LA
    Shear, NH
    Arlette, JP
    Cloutier, R
    Danby, FW
    Elewski, BE
    GarnisJones, S
    Giroux, JM
    Gratton, D
    Gulliver, W
    Hull, P
    Jones, HE
    Journet, M
    Krol, AL
    Leyden, JJ
    Maddin, SC
    Ross, JB
    Savin, RC
    Scher, RK
    Sibbald, GR
    Tawfik, NH
    Zaias, N
    Tolpin, M
    Evans, S
    Marsolais, C
    Chin, T
    Lin, TH
    Maher, T
    Birnbaum, JE
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1997, 37 (05) : 740 - 745
  • [7] LION-Study:: efficacy and tolerability of continuous terbinafine (Lamisil®) compared to intermittent itraconazole in the treatment of toenail onychomycosis
    Sigurgeirsson, B
    Billstein, S
    Rantanen, T
    Ruzicka, T
    Di Fonzo, E
    Vermeer, BJ
    Goodfield, MJD
    Evans, EGV
    BRITISH JOURNAL OF DERMATOLOGY, 1999, 141 : 5 - 14
  • [8] A study to compare efficacy of various oral antifungals (Fluconazole, Terbinafine, Itraconazole) in treatment of Onychomycosis
    Vora, Deval N.
    Bharti
    Solanki, Pooja
    Kothari, Anuj
    Meher, Kamalini
    JOURNAL OF RESEARCH IN MEDICAL AND DENTAL SCIENCE, 2014, 2 (04): : 49 - 52
  • [9] A multicentre, randomized, controlled study of the efficacy, safety and cost-effectiveness of a combination therapy with amorolfine nail lacquer and oral terbinafine compared with oral terbinafine alone for the treatment of onychomycosis with matrix involvement
    Baran, R.
    Sigurgeirsson, B.
    de Berker, D.
    Kaufmann, R.
    Lecha, M.
    Faergemann, J.
    Kerrouche, N.
    Sidou, F.
    BRITISH JOURNAL OF DERMATOLOGY, 2007, 157 (01) : 149 - 157
  • [10] Cost effectiveness of continuous terbinafine compared with intermittent itraconazole in the treatment of dermatophyte toenail onychomycosis - An analysis based on results from the LION study
    Jansen, R
    Redekop, WK
    Rutten, FFH
    PHARMACOECONOMICS, 2001, 19 (04) : 401 - 410
12345